Cost-utility analysis of surgical revascularization versus conservative management for adult moyamoya disease patients with posterior hemorrhage in Japan
Year: 2026
Type: article
Abstract: AIMS: This study evaluates the cost-effectiveness of surgical revascularization versus conservative management for adult moyamoya disease (MMD) patients with posterior hemorrhage from the perspective of the Japanese public healthcare payer. MATERIALS AND METHODS: We developed a combined decision tree and Markov model for adult posterior hemorrhagic MMD patients (mean age: 41 years; baseline modified Rankin Scale [mRS] 0-2) over a 60-year lifetime horizon with 1-year cycles. We estimated the treatment effect using the composite endpoint hazard ratio (0.07) from the JAM Trial posterior hemorrhage subgroup as a proxy for the effect on recurrent hemorrhage. We informed health utilities with recent EQ-5D-5L data from the Fukuoka Stroke Registry, weighted by the Japan Stroke Data Bank. We estimated direct medical costs based on the national fee schedule. We discounted costs and outcomes at 2% annually. We set the willingness-to-pay threshold at JPY 7,500,000 per quality-adjusted life year (QALY). RESULTS: In the base case, surgical revascularization yielded 21.49 QALYs for JPY 6,323,426 (USD 40,302), compared with 15.59 QALYs and JPY 5,308,637 (USD 33,835) for conservative management. The incremental cost-effectiveness ratio was JPY 172,220 (USD 1,098) per QALY, which falls below the reference value of JPY 7,500,000 per QALY. In scenario analyses with 5- and 10-year horizons, the ICERs were JPY 8,926,784 and JPY 2,031,693 per QALY, respectively. Probabilistic sensitivity analysis also favored surgical revascularization across the modeled parameter distributions. LIMITATIONS: The base-case estimate of surgical efficacy was based on a composite outcome from a small subgroup, and long-term recurrence risks beyond the 5-year trial period remain uncertain. CONCLUSION: Surgical revascularization is likely to be cost-effective for adult MMD patients with posterior hemorrhage within the Japanese healthcare system, although limited evidence leaves uncertainty about long-term rebleeding risks and the durability of surgical benefit.
Source: Journal of Medical Economics
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funder: Hokkaido University
OpenAlex ID: W7225901534
